Sen-Jam Pharmaceutical

Not Your Ordinary Pharma Company

Company Information



Pharmaceuticals / Drugs


Huntington, NY

Sen-Jam Pharmaceutical makes affordable, safe drugs that work.

This isn’t your ordinary pharma company. It’s a group of scientists, pharmacists, and pain experts on a mission to bring the world medications that are safe, effective, and affordable.

The company’s treatments center around inflammation, believed to be the root cause of many ailments. Despite this theory, consumers don’t have many options that address inflammation.

Sen-Jam has repurposed two small molecules that have an effect on inflammation, helping to prevent problems before they need solving. The company’s lead creations include oral therapeutics for Covid-19, opioid withdrawal, and alcohol-related hangover prevention. This represents a seventeen-billion-dollar opportunity in the U.S.

Sen-Jam is on an accelerated 505(b) regulatory pathway. Its immediate goal is to move forward with clinical trials, with plans to sell and license its medications by 2025.

Team Background

Jim Iversen - Co-Founder & CEO
Jackie Iversen - Co-Founder
$1.07 million
$850K (79%)
Current Valuation
$25 million Cap / 0% Discount
Min. Investment
Deal Type
Title III
(For all investors)
Offering Type
Convertible Debt
Finance History
  • $613K
    (Convertible Note)
Learn more on WeFunder